Optimi Health Obtains U.S. FDA Drug Establishment Registration
The Company is now recognized by the U.S. FDA to support the cross-border supply of GMP MDMA and psilocybin to...
Clinical Trial
Best Supplements For Muscle Growth: Top Legal Bodybuilding Supplements & Anabolic Steroids For Bulking, Cutting & Strength
Backed by Wolfson Brands (UK) Limited, Discover the best supplements for muscle growth, including top legal alternatives to anabolic steroids...
Bioma Review 2025: Revolutionizing Gut Health or Just Another Fad? Honest Analysis Inside By Bioma Probiotic!
Gut transformation through Bioma a perfectly blended combination of probiotics prebiotics and postbiotics Bioma Bioma New York City, May 03,...
RaySearch Laboratories and Vision RT present innovations in surface guided treatment planning at ESTRO
STOCKHOLM, May 3, 2025 /PRNewswire/ -- At this week's ESTRO conference in Vienna, RaySearch Laboratories AB (publ) and Vision RT...
Life Science Analytics Market worth $68.81 billion by 2030 11.4% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued at US$35.69 billion in 2024,...
Landmark Science Makes RWE Services for Biopharma Industry a Boutique Experience
LOS ANGELES, May 2, 2025 /PRNewswire/ -- Landmark Science, a premier provider of real-world evidence (RWE) solutions, is redefining industry...
Virgo launches EndoML, a state-of-the-art AI development platform for gastroenterologists and pharmaceutical researchers, at DDW 2025
SAN DIEGO, May 2, 2025 /PRNewswire/ -- Virgo Surgical Video Solutions, Inc., a leader in endoscopic AI technologies, today announced...
Aktiia secures $42 million in Series B funding round and rebrands to Hilo
With fresh funding round, the health tech pioneer continues to work toward managing the world's blood pressure. LONDON, May 2,...
Alzheimer’s Drug Discovery Foundation’s Diagnostics Accelerator (DxA) Partners with Siemens Healthineers to License DxA’s SpeechDx Dataset, Gold-Standard Dataset for Alzheimer’s Speech Biomarkers
Siemens is the first of many partners to non-exclusively license SpeechDx's speech and clinical dataset with the goal of developing...
Epicore Biosystems Expands Series B to $32M to Power Global Growth of Sweat-Sensing Wearable Technology
New investment fuels expansion of Connected Hydration wearables, cloud analytics and next-gen biomarker validation CAMBRIDGE, Mass., May 1, 2025 /PRNewswire/...
Sona Nanotech Announces Annual Options Grants
Halifax, Nova Scotia--(Newsfile Corp. - May 1, 2025) - Sona Nanotech Inc. (CSE: SONA), (OTCQB: SNANF) (the "Company" or "Sona")...
Lyell Immunopharma Announces Oral Presentation of New Clinical Data from the Phase 1/2 Trial of LYL314 for the Treatment of Large B-cell Lymphoma at the International Conference on Malignant Lymphoma (ICML) 2025
SOUTH SAN FRANCISCO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a...
Precision Neuroscience Adds Med-Tech Veterans To Accelerate Commercialization
John Woock joins as Chief Business Officer; Konstantinos Alataris, PhD, appointed to Board of DirectorsNEW YORK, May 01, 2025 (GLOBE...
Dupixent® (dupilumab) Data Presented at ATS Reinforce Impact of Targeting Key Type 2 Inflammation Drivers to Improve Outcomes for Chronic Respiratory Diseases
24 abstracts, including 1 oral presentation and 4 late-breaking posters on Dupixent, to showcase new clinical and real-world analyses in...
BioCardia Announces First Patient in Phase 3 Randomized Controlled Double-Blind CardiAMP HF II Clinical Trial of the Company’s Lead Cell Therapy for Treatment of Heart Failure
SUNNYVALE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. , a global leader in cellular and cell-derived therapeutics for the...
Akari Therapeutics Appoints Mark F. Kubik as Head of Business Development – Oncology
Global expertise in establishing and executing transformative transactions which have led to multiple approved therapeutic products Successful track record across...
Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
MIAMI, May 01, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing...
Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders
New patent covers a treatment method for a broad spectrum of alcohol-related disorders, including additional conditions associated with alcohol useGLEN...
Windtree Announces Strategic Transaction to Drive Revenue Generation in Support of Ongoing Therapeutic Pipeline Development
Initial transaction provides the right to buy the target asset which may provide consistent revenue to Windtree while it continues...
4DMT Announces RMAT Designation Granted by FDA for 4D-150 for DME
EMERYVILLE, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology...